RxSight annual revenue
2020
2021
2022
2023
2024
2025
RxSight Revenue Growth & History (RXST)
RxSight reported $134.5M in revenue for fiscal 2025, a decrease of 3.89% from the previous fiscal year.
View full RxSight company overviewRxSight annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $134.5M | −$5.4M | −3.89% |
| 2024 | 2024-12-31 | $139.9M | $50.9M | +57.09% |
| 2023 | 2023-12-31 | $89.1M | $40.1M | +81.77% |
| 2022 | 2022-12-31 | $49.0M | $26.4M | +116.90% |
| 2021 | 2021-12-31 | $22.6M | $7.9M | +53.92% |
| 2020 | 2020-12-31 | $14.7M | — | — |
RxSight quarterly revenue
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $27.2M | −$6.4M | −19.01% |
| Q1 2026 | 2026-03-31 | $30.9M | −$7.0M | −18.48% |
| Q4 2025 | 2025-12-31 | $32.6M | −$7.6M | −18.92% |
| Q3 2025 | 2025-09-30 | $30.3M | −$5.0M | −14.09% |
| Q2 2025 | 2025-06-30 | $33.6M | −$1.3M | −3.58% |
| Q1 2025 | 2025-03-31 | $37.9M | $8.4M | +28.41% |
| Q4 2024 | 2024-12-31 | $40.2M | $11.6M | +40.71% |
| Q3 2024 | 2024-09-30 | $35.3M | $13.1M | +59.08% |
| Q2 2024 | 2024-06-30 | $34.9M | $14.1M | +67.65% |
| Q1 2024 | 2024-03-31 | $29.5M | $12.0M | +68.75% |
| Q4 2023 | 2023-12-31 | $28.6M | $12.5M | +77.64% |
| Q3 2023 | 2023-09-30 | $22.2M | $9.6M | +75.97% |
| Q2 2023 | 2023-06-30 | $20.8M | $9.4M | +83.19% |
| Q1 2023 | 2023-03-31 | $17.5M | $8.5M | +95.58% |
| Q4 2022 | 2022-12-31 | $16.1M | $7.7M | +90.93% |
| Q3 2022 | 2022-09-30 | $12.6M | $6.8M | +118.03% |
| Q2 2022 | 2022-06-30 | $11.4M | $6.5M | +131.98% |
| Q1 2022 | 2022-03-31 | $8.9M | $5.5M | +156.66% |
| Q4 2021 | 2021-12-31 | $8.4M | — | — |
| Q3 2021 | 2021-09-30 | $5.8M | $1.6M | +38.75% |
| Q2 2021 | 2021-06-30 | $4.9M | $2.2M | +80.97% |
| Q1 2021 | 2021-03-31 | $3.5M | — | — |
| Q3 2020 | 2020-09-30 | $4.2M | — | — |
| Q2 2020 | 2020-06-30 | $2.7M | — | — |
RxSight revenue growth trends
Over the last five reported fiscal years, revenue grew from $14.7M to $134.5M, a compound annual growth rate of 55.74%. RxSight's latest reported quarter, Q2 2026, generated $27.2M in revenue, a decrease of 19.01% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review RxSight source filings ↗